LY-3200882
| CAS No. | 1898283-02-7 | Cat. No. | BCP20882 |
| Name | LY-3200882 | ||
| Synonyms | LY 3200882; LY3200882; | ||
| Formula | C24H29N5O3 | M. Wt | 435.52 |
| Description | LY-3200882 is an orally active TGFbeta inhibitor. LY3200882 targets transforming growth factor-beta (TGFb), with potential antineoplastic activity. Upon administration, LY3200882 specifically targets and binds to TGFb, which prevents both the binding of TGFb to its receptor TGFbR and TGFb-mediated signal transduction. This may lead to a reduction in TGFb-dependent proliferation of cancer cells. | ||
| Pathways | TGF beta/Smad Wnt/Stem Cell | ||
| Targets | BMP/TGF beta Receptor TGF β/Smad | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.